65.21
price up icon0.71%   0.44
 
loading
Precedente Chiudi:
$64.77
Aprire:
$64.77
Volume 24 ore:
341.93K
Relative Volume:
0.46
Capitalizzazione di mercato:
$3.65B
Reddito:
$76.81M
Utile/perdita netta:
$-162.42M
Rapporto P/E:
-21.81
EPS:
-2.99
Flusso di cassa netto:
$-122.49M
1 W Prestazione:
+3.54%
1M Prestazione:
+5.29%
6M Prestazione:
-17.51%
1 anno Prestazione:
+20.53%
Intervallo 1D:
Value
$63.77
$66.21
Intervallo di 1 settimana:
Value
$61.51
$66.21
Portata 52W:
Value
$47.86
$107.37

Arcellx Inc Stock (ACLX) Company Profile

Name
Nome
Arcellx Inc
Name
Telefono
240-327-0603
Name
Indirizzo
800 BRIDGE PARKWAY, REDWOOD CITY
Name
Dipendente
163
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ACLX's Discussions on Twitter

Confronta ACLX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ACLX
Arcellx Inc
65.18 3.65B 76.81M -162.42M -122.49M -2.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.60 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
517.54 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.38 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
240.05 28.51B 3.81B -644.79M -669.77M -6.24

Arcellx Inc Stock (ACLX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-10-08 Iniziato Redburn Atlantic Buy
2024-09-03 Iniziato Cantor Fitzgerald Overweight
2024-05-31 Iniziato Piper Sandler Overweight
2024-03-07 Iniziato Morgan Stanley Overweight
2024-01-04 Reiterato Needham Buy
2023-12-19 Iniziato Scotiabank Sector Outperform
2023-10-30 Iniziato TD Cowen Outperform
2023-10-17 Iniziato UBS Buy
2023-05-18 Iniziato Truist Buy
2023-04-14 Iniziato Robert W. Baird Outperform
2023-03-14 Iniziato Stifel Buy
2023-02-13 Iniziato H.C. Wainwright Buy
2022-12-13 Ripresa BofA Securities Buy
2022-10-31 Iniziato Guggenheim Buy
2022-10-27 Iniziato Needham Buy
2022-07-20 Iniziato Canaccord Genuity Buy
2022-03-01 Iniziato BofA Securities Buy
2022-03-01 Iniziato SVB Leerink Outperform
Mostra tutto

Arcellx Inc Borsa (ACLX) Ultime notizie

pulisher
Jun 17, 2025

Citi initiates Arcellx stock with buy rating on cell therapy potential - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citi initiates Arcellx stock with buy rating on cell therapy potential By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Cancer Cell Market Exclusive Report with Detailed Study Analysis | Abbott Laboratories, Cellectis, Arcellx, GE - newstrail.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citigroup Initiates Arcellx at Buy With $110 Price Target - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Arcellx initiated with a Buy at Citi - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Arcellx (ACLX): Citi Initiates Buy Rating with Promising Outlook | ACLX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Aileen Fernandes | People on The MoveSan Francisco Business Times - The Business Journals

Jun 16, 2025
pulisher
Jun 16, 2025

Aileen Fernandes - The Business Journals

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Anito-cel: A Promising Market Entrant with Superior Efficacy and Safety in Multiple Myeloma Treatment - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Anito Cel Therapy: A Promising Contender in Multiple Myeloma Treatment with Strong Market Potential - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

ACLX: HC Wainwright & Co. Reiterates Buy Rating with $115 Target | ACLX Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx stock maintains buy rating at H.C. Wainwright on launch plans - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Strategic Partnership with Kite Enhances Anito-cel Therapy Launch and Market Position - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Promising Potential of Arcellx Inc’s Anito-cel Therapy Drives Buy Rating - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Positive Outlook for Arcellx Inc: Promising Anito-cel Therapy and Strategic Market Positioning - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Promising Market Position and Growth Potential in Multiple Myeloma Therapy - TipRanks

Jun 16, 2025
pulisher
Jun 14, 2025

Rhumbline Advisers Raises Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Transcript : Arcellx, Inc.Special Call - MarketScreener

Jun 13, 2025
pulisher
Jun 12, 2025

(ACLX) Technical Data - news.stocktradersdaily.com

Jun 12, 2025
pulisher
Jun 12, 2025

Arcellx’s SWOT analysis: CAR-T pioneer’s stock poised for myeloma market shake-up - Investing.com

Jun 12, 2025
pulisher
Jun 11, 2025

arcellx director Kavita Patel sells shares worth $101,040 By Investing.com - Investing.com Nigeria

Jun 11, 2025
pulisher
Jun 11, 2025

arcellx director Kavita Patel sells shares worth $101,040 - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Brokers Set Expectations for Arcellx FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Two Sigma Investments LP - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

FY2026 EPS Estimates for Arcellx Lifted by Leerink Partnrs - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Squarepoint Ops LLC Sells 4,670 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Arcellx FY2029 EPS Forecast Raised by Leerink Partnrs - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Kalkine: Top NASDAQ Stocks Arcellx’s Role by Kalkine - Kalkine Media

Jun 05, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Acquires 1,100 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Raises Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Sells 945 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Arcellx, Inc. (NASDAQ:ACLX) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jun 03, 2025
pulisher
May 31, 2025

How to Take Advantage of moves in (ACLX) - news.stocktradersdaily.com

May 31, 2025
pulisher
May 29, 2025

Nuveen Asset Management LLC Sells 9,110 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

May 29, 2025
pulisher
May 28, 2025

Arcellx Inc Holds Annual Stockholders Meeting - TipRanks

May 28, 2025
pulisher
May 23, 2025

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs - Benzinga

May 23, 2025
pulisher
May 22, 2025

Thinking Of Buying Arcellx Inc (NASDAQ: ACLX) Stock? Here’s What You Need To Know - Stocksregister

May 22, 2025
pulisher
May 21, 2025

Annual Oncology Innovation Summit and Its Investor Event During EHA2025 - Business Wire

May 21, 2025
pulisher
May 21, 2025

Arcellx Announces Its Participation at TD Cowen’s 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025 - Bluefield Daily Telegraph

May 21, 2025
pulisher
May 21, 2025

Dycom Industries Posts Upbeat Earnings, Joins WeRide, Keysight Technologies And Other Big Stocks Moving Higher On Wednesday - Benzinga

May 21, 2025
pulisher
May 20, 2025

Baron Discovery Fund Initiated a Position in Arcellx (ACLX) - Insider Monkey

May 20, 2025
pulisher
May 19, 2025

BNP Paribas Financial Markets Makes New $1.53 Million Investment in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

May 19, 2025
pulisher
May 16, 2025

Arcellx Inc (ACLX) Receives a Buy from Canaccord Genuity - The Globe and Mail

May 16, 2025
pulisher
May 16, 2025

Mercer Global Advisors Inc. ADV Takes $278,000 Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

May 16, 2025
pulisher
May 16, 2025

Arcellx, Inc. Reports Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 15, 2025

Arcellx Inc’s Anito-cel Shows Promising Results in Phase 2 Trial, Earning Buy Rating from Analyst - TipRanks

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald Expects Reduced Earnings for Arcellx - Defense World

May 15, 2025
pulisher
May 14, 2025

Insiders At Arcellx Sold US$2.6m In Stock, Alluding To Potential Weakness - simplywall.st

May 14, 2025
pulisher
May 14, 2025

Promising Clinical Data and Strong Safety Profile Lead to Buy Rating for Arcellx Inc’s Anito-cel - TipRanks

May 14, 2025
pulisher
May 14, 2025

Arcellx Inc’s Anito-cel Shows Promising Efficacy and Safety in Multiple Myeloma, Earning Buy Rating - TipRanks

May 14, 2025
pulisher
May 14, 2025

Arcellx's Potential Multiple Myeloma Treatment Shows 97% Overall Response Rate in Phase 2 Study; Shares Rise - marketscreener.com

May 14, 2025

Arcellx Inc Azioni (ACLX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Arcellx Inc Azioni (ACLX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Patel Kavita
Director
Jun 10 '25
Sale
67.36
1,500
101,040
0
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
Capitalizzazione:     |  Volume (24 ore):